 | Up a level |
Ochoa, E., Martin, J. -E., Assassi, S., Beretta, L., Carreira, P., Guillen, A., Simeon, C. P., Koumakis, E., Dieude, P., Allanore, Y., Garcia-Hernandez, F. J., Espinosa, G., Castellvi, I., Trapiella, J. L., Rodriguez, L., Gonzalez-Gay, M. A., Egurbide, M. V., Saez, L., Callejas-Rubio, J. L., Vargas-Hitos, J. A., Hunzelmann, N., Riemekasten, G., Witte, T., Distler, J. H. W., Kreuter, A., Lunardi, C., Santaniello, A., Tan, F. K., Shiels, P. G., Herrick, A., Worthington, J., Vonk, M. C., Koeleman, B. P., Radstake, T. R. D. J., Mayes, M. D. and Martin, J. (2015). Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. Clin. Exp. Rheumatol., 33 (4). S. S31 - 5. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X